Stock DUL ALNYLAM PHARMACEUTICALS, INC.
Add to a list
To use this feature you must be a member
Log inSign up

Calendar Alnylam Pharmaceuticals, Inc. Börse Stuttgart

Equities

DUL

US02043Q1076

Real-time Estimate Tradegate
Other stock markets
 10:18:43 28/06/2024 BST 		5-day change 1st Jan Change
230.6 EUR -0.15% Intraday chart for Alnylam Pharmaceuticals, Inc. +59.42% +31.55%
06-27 Stifel Adjusts Price Target on Alnylam Pharmaceuticals to $295 From $215, Maintains Buy Rating MT
06-27 RBC Raises Price Target on Alnylam Pharmaceuticals to $265 From $250, Keeps Outperform Rating MT

Chart calendar Alnylam Pharmaceuticals, Inc.

0eccb.hKazSyUhqij1B1N2XgBycPZoS4IYVDJtI7ZcZSQqg90.5tb3EWtPz329TikAJ2caJJUBGfZZY1Mke8QVLBEcypbN5_w6ZFfSfYdfZw~d7663784099da15086de804b3330e54e

Upcoming events on Alnylam Pharmaceuticals, Inc.

30/07/2024 Q2 2024 Earnings Release (Projected)
23/10/2024 Q3 2024 Earnings Release (Projected)
05/02/2025 Q4 2024 Earnings Release (Projected)
30/04/2025 Q1 2025 Earnings Release (Projected)

Past events on Alnylam Pharmaceuticals, Inc.

24/06/2024 13:00 HELIOS-B Phase 3 StudyResults Call
16/05/2024 15:30 Annual General Meeting
02/05/2024 13:30 Q1 2024 Earnings Call
02/05/2024 13:00 Q1 2024 Earnings Release
08/04/2024 00:00 KARDIA-2 Phase 2 Study Results Call
25/03/2024 17:00 Canaccord Genuity Genetic Medicine for Generalists Conference
20/03/2024 14:00 Stifel CNS Day
12/03/2024 14:15 Barclays Global Healthcare Conference
05/03/2024 14:10 TD Cowen Health Care Conference
15/02/2024 13:30 Q4 2023 Earnings Call
15/02/2024 13:00 Q4 2023 Earnings Release
08/01/2024 17:45 JPMorgan Healthcare Conference
13/12/2023 13:30 R&D Day
29/11/2023 14:30 Piper Sandler Healthcare Conference
14/11/2023 14:45 Stifel Healthcare Conference
14/11/2023 10:00 Jefferies London Healthcare Conference
02/11/2023 12:30 Q3 2023 Earnings Call
02/11/2023 12:00 Q3 2023 Earnings Release
24/10/2023 Clinical Trials on Alzheimers Disease Conference
09/10/2023 13:30 ONPATTRO FDA Approval Call

Annual results

Fiscal PeriodDecember 2019 2020 2021 2022 2023 2024
Net sales
Million USD		Released
Forecast
Spread 		220
221
-0.43%		493
476
3.49%		844
823
2.64%		1 037
1 013
2.41%		1 828
1 827
0.1%
1 875

EBITDA
Million USD		Released
Forecast
Spread 		-885
-857
-3.28%		-794
-773
-2.74%		-661
-608
-8.65%		-741
-646
-14.71%		0,00
-250
-
-322

EBIT
Million USD		Released
Forecast
Spread 		-939
-893
-5.24%		-828
-833
0.51%		-709
-665
-6.58%		-785
-813
3.38%		-282
-275
-2.6%
-374

Earnings before Tax (EBT)
Million USD		Released
Forecast
Spread 		-885
-853
-3.84%		-856
-826
-3.59%		-852
-750
-13.68%		-1 127
-1 138
1%		-434
-437
0.72%
-466

Net income
Million USD		Released
Forecast
Spread 		-886
-860
-3.08%		-858
-832
-3.22%		-853
-758
-12.46%		-1 131
-1 156
2.16%		-440
-441
0.12%
-458

EPS
USD		Released
Forecast
Spread 		-8,11
-7,93
-2.21%		-7,46
-7,18
-3.86%		-7,20
-6,42
-12.12%		-9,30
-9,42
1.32%		-3,52
-3,53
0.29%
-3,58

Announcement Date06/02/2011/02/2110/02/2223/02/2315/02/24-

Quarterly results

Fiscal PeriodDecember 2022 Q1 2022 Q2 2022 Q3 2022 Q4 2023 Q1 2023 Q2 2023 Q3 2023 Q4 2024 Q1 2024 Q2 2024 Q3 2024 Q4 2025 Q1 2025 Q2
Net sales
Million USD		Released
Forecast
Spread 		213
243
-12.17%		225
256
-12.2%		264
292
-9.38%		335
312
7.23%		319
313
2.16%		319
351
-9.08%		751
395
90.22%		440
442
-0.58%		494
427
15.82%
446


460


470


504


528

EBITDA
Million USD		Released
Forecast
Spread 		-137
-200
31.43%		-182
-206
11.98%		-247
-118
-110.59%		-174
-185
5.58%		-136
-204
33.36%		-217
-135
-60.01%		227
-134
269.42%
-143

-29,9
-123
75.76%
-115


-79,7


-56,9







EBIT
Million USD		Released
Forecast
Spread 		-147
-211
30.37%		-192
-173
-11.02%		-258
-195
-32.42%		-189
-221
14.57%		-150
-180
16.95%		-230
-136
-69.1%		214
-165
229.79%		-116
-114
-2.24%		-43,4
-117
62.87%
-117


-113


-114


-110


-119

Earnings before Tax (EBT)
Million USD		Released
Forecast
Spread 		-239
-234
-2.18%		-275
-206
-33.41%		-406
-224
-81.14%		-207
-266
22.17%		-172
-237
27.24%		-274
-162
-68.79%		151
-206
173.12%		-138
-149
7.5%		-63,6
-133
52.26%
-139


-141


-141


-131


-146

Net income
Million USD		Released
Forecast
Spread 		-240
-235
-2.25%		-277
-205
-35.27%		-406
-221
-84.03%		-207
-234
11.5%		-174
-217
19.87%		-276
-168
-64.42%		148
-184
180.46%		-138
-157
12.18%		-65,9
-140
53.05%
-138


-137


-143


-133


-148

EPS
USD		Released
Forecast
Spread 		-2,00
-1,90
-5.45%		-2,29
-1,64
-39.55%		-3,32
-1,81
-83.85%		-1,68
-1,93
12.92%		-1,40
-1,73
19.14%		-2,21
-1,42
-56.08%		1,18
-1,47
180.25%		-1,10
-1,25
11.8%		-0,52
-1,15
54.62%
-1,10


-1,06


-1,08


-0,96


-0,94

Announcement Date28/04/2228/07/2227/10/2223/02/2304/05/2303/08/2302/11/2315/02/2402/05/24-----

Upcoming sector events for Alnylam Pharmaceuticals, Inc.

15/07/2024 06:45 ADDLIFE AB: Q2 2024 Earnings Release
21/07/2024 MEDPACE HOLDINGS, INC.: Q2 2024 Earnings Release
23/07/2024 SYNGENE INTERNATIONAL LIMITED: Q1 2025 Earnings Release (Projected)
23/07/2024 ALKERMES PLC: Q2 2024 Earnings Release (Projected)
23/07/2024 IQVIA HOLDINGS INC.: Q2 2024 Earnings Release (Projected)
23/07/2024 ICON PUBLIC LIMITED COMPANY: Q2 2024 Earnings Release (Projected)
24/07/2024 LONZA GROUP AG: Q2 2024 Earnings Release
25/07/2024 06:00 BACHEM HOLDING AG: Q2 2024 Earnings Release
25/07/2024 PHARVARIS N.V.: Q2 2024 Earnings Release (Projected)
26/07/2024 06:00 BB BIOTECH AG: Q2 2024 Earnings Release
More events

Past sector events for Alnylam Pharmaceuticals, Inc.

07/06/2024 07:57 POLARIS GROUP: May 2024 Sales and Revenue Release
29/05/2024 21:01 IMMUNOVANT, INC.: Q4 2024 Earnings Release
23/05/2024 12:00 CUREVAC N.V.: Q1 2024 Earnings Release
22/05/2024 06:00 EVOTEC SE: Q1 2024 Earnings Release
21/05/2024 22:14 ALVOTECH: Q1 2024 Earnings Release
21/05/2024 12:00 EXSCIENTIA PLC: Q1 2024 Earnings Release
17/05/2024 07:00 BIOARCTIC AB: Q1 2024 Earnings Release
15/05/2024 21:05 CULLINAN THERAPEUTICS, INC.: Q1 2024 Earnings Release
15/05/2024 12:00 PERSPECTIVE THERAPEUTICS, INC.: Q1 2024 Earnings Release
14/05/2024 GNI GROUP LTD.: Q1 2024 Earnings Release

Net sales - Quarter - Rate of surprise

Quarterly earnings - Rate of surprise

Net sales - Annual - Rate of surprise

Annual profits - Rate of surprise

  1. Stock Market
  2. Equities
  3. ALNY Stock
  4. DUL Stock
  5. Calendar Alnylam Pharmaceuticals, Inc.